6/27/2025

Johnson & Johnson (NYSE:JNJ) is one of the Best Wide Moat Dividend Stocks to Invest in. Johnson & Johnson (NYSE:JNJ) is a long-established leader in the healthcare industry, with a strong portfolio of high-performing drugs in areas like immunology and cancer treatment, along with a thriving medical devices business. In 2023, the company separated its […]

Source: Yahoo

6/26/2025

Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio NORTHAMPTON, MA / ACCESS Newswire / June 26, 2025 / Kenvue Inc. (NYSE:KVUE), maker ...

Source: Yahoo

6/24/2025

SUMMIT, N.J. - June 24, 2025 - Kenvue Inc. today announced the appointment of Anindya Dasgupta as the Company's Group President, Asia Pacific, effective July 14, 2025. Mr. Dasgupta will join Kenvue...

Source: Finnhub

6/24/2025

Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.

Source: SeekingAlpha

6/23/2025

JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.

Source: Yahoo

6/23/2025

Today we're going to take a look at the well-established Kenvue Inc. ( NYSE:KVUE ). The company's stock received a lot...

Source: Yahoo

6/23/2025

As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif Droke, editor of Cabot Turnaround Letter.

Source: Yahoo

6/21/2025

Johnson & Johnson (NYSE:JNJ) is among the best dividend stocks for a bear market. The company is facing a combination of slow revenue growth, unresolved legal battles over talc products, and looming drug price negotiations under new Medicare rules. These issues could weigh on investor sentiment and profitability in the near term. Despite current challenges, […]

Source: Yahoo

6/20/2025

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys. Learn strategies for maximizing income and navigating market risks.

Source: SeekingAlpha

6/18/2025

Kenvue faces demand weakness, retailer destocking, and price cuts, raising concerns about structural issues and recovery. Learn more on KVUE stock here.

Source: SeekingAlpha

6/15/2025

Harris Associates' Q1 2025 portfolio shifts reveal major stake changes in top stocks like ConocoPhillips and Airbnb.

Source: SeekingAlpha

6/13/2025

Kenvue Inc. stock falls Friday, underperforms market

Source: MarketWatch

6/13/2025

Stock index futures slide as Israel attacks Iran. Kenvue considering selling some skin, beauty brands - report. Frito-Lay shutting down production at Southern California plant.

Source: SeekingAlpha

6/12/2025

NEW YORK (Reuters) -Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an underperforming business segment to focus on core products. The company, which was spun out of Johnson & Johnson in 2023, is zeroing in on smaller brands in the unit to sell such as Clean & Clear, Maui Moisture, Neostrata, its German baby care brand Bebe, and Japanese brand Dr.Ci:Labo, the sources said. It plans to hold onto the bigger names in the unit, such as Neutrogena and Aveeno, the sources said.

Source: Yahoo

6/11/2025

Kenvue Inc. stock rises Wednesday, outperforms market

Source: MarketWatch

6/10/2025

Kenvue Inc. stock rises Tuesday, outperforms market

Source: MarketWatch

6/9/2025

Kenvue Inc. stock falls Monday, underperforms market

Source: MarketWatch

6/7/2025

Source: SeekingAlpha

6/4/2025

Investing.com -- Jefferies believes investors should take advantage of recent weakness in Kenvue (NYSE:KVUE) stock, reiterating a Buy rating and calling the company a “self-help transformation story” after a 6% share decline on Tuesday.

Source: Yahoo

6/4/2025

Source: SeekingAlpha